US Patent 10179909 Non-natural amino acid tRNA synthetases for pyridyl tetrazine
Patent 10179909 was granted and assigned to Sutro Biopharma, Inc. on January, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+382 characters)
Article
Patent abstract
The invention provides methods and compositions for a mutein aminoacyl-tRNA synthetase that preferentially charges a tRNA with a non-natural amino acid. Also provided are methods for incorporating the non-natural amino acids, pyridinyl-amino tetrazine amino acids, into a protein, and further conjugating a biologically active adduct to the pyridinyl-amino tetrazine.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Christopher Thanos0
Erik S. Zimmerman0
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
101799090
Date of Patent
January 15, 2019
0Patent Application Number
159688940
Date Filed
May 2, 2018
0Patent Primary Examiner
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10179909 Non-natural amino acid tRNA synthetases for pyridyl tetrazine
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10179909
Date of patent
January 15, 2019
Patent application number
15968894
Date Filed
May 2, 2018
Patent primary examiner
Find more entities like US Patent 10179909 Non-natural amino acid tRNA synthetases for pyridyl tetrazine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
